China Drug Screening Market Size & Outlook, 2025-2030

The drug screening market in China is expected to reach a projected revenue of US$ 591.4 million by 2030. A compound annual growth rate of 5% is expected of China drug screening market from 2025 to 2030.
Revenue, 2024 (US$M)
$443.3
Forecast, 2030 (US$M)
$591.4
CAGR, 2025 - 2030
5%
Report Coverage
China

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China drug screening market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China drug screening market highlights

  • The China drug screening market generated a revenue of USD 443.3 million in 2024 and is expected to reach USD 591.4 million by 2030.
  • The China market is expected to grow at a CAGR of 5% from 2025 to 2030.
  • In terms of segment, instruments was the largest revenue generating product in 2024.
  • Services & Others is the most lucrative product segment registering the fastest growth during the forecast period.


Drug screening market data book summary

Market revenue in 2024USD 443.3 million
Market revenue in 2030USD 591.4 million
Growth rate5% (CAGR from 2025 to 2030)
Largest segmentInstruments
Fastest growing segmentServices & Others
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Services & Others, Rapid Testing Devices, Consumables
Key market players worldwideAbbott Laboratories, Quest Diagnostics Inc, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Labcorp Holdings Inc, OraSure Technologies Inc, Omega Laboratories, Draegerwerk AG & Co KGaA, Bio-Rad Laboratories Inc Class A


Other key industry trends

  • In terms of revenue, China accounted for 4.7% of the global drug screening market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China drug screening market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 377.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Screening Market Companies

Name Profile # Employees HQ Website
Bio-Rad Laboratories Inc Class A View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
OraSure Technologies Inc View profile 638 220 East First Street, Bethlehem, PA, United States, 18015 https://www.orasure.com
Omega Laboratories View profile 101-250 Mogadore, Ohio, United States, North America https://www.omegalaboratories.com/
Draegerwerk AG & Co KGaA View profile 16476 Moislinger Allee 53–55, Lubeck, Germany, 23542 https://www.draeger.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

China drug screening market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug screening market will help companies and investors design strategic landscapes.


Instruments was the largest segment with a revenue share of 44.71% in 2024. Horizon Databook has segmented the China drug screening market based on instruments, services & others, rapid testing devices, consumables covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China drug screening market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China drug screening market databook

  • Our clientele includes a mix of drug screening market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China drug screening market , including forecasts for subscribers. This country databook contains high-level insights into China drug screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China drug screening market size, by product, 2018-2030 (US$M)

China Drug Screening Market Outlook Share, 2024 & 2030 (US$M)

China drug screening market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online